BGM0504 placebo

DRUG2 trials

Sponsors

BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd., BrightGene Bio-Medical Technology Co., Ltd.

Conditions

Overweight or Obese Participants Without DiabetesOverweight or Obesity

Phase 2

A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes

Not yet recruitingNCT07658560

BrightGene Bio-Medical Technology Co., Ltd.Overweight or Obese Participants Without Diabetes

Start: 2026-06-30End: 2027-02-28Target: 200Updated: 2026-06-22

Phase 3

A Study of BGM0504 Injection in Participants with Obesity or Overweight

RecruitingNCT06704581

BrightGene New Bio-Medical Technology(Wuxi) Co.Ltd.Overweight or Obesity

Start: 2024-10-28End: 2026-03-27Target: 620Updated: 2024-11-26